Kerry   Report issue

For profit Phase 4
Founded: Tralee Ireland (1972)
Status: No NME R&D (1972)

Organization Overview

First Clinical Trial
2015
NCT05584254
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

KERRY GROUP P.L.C.

Active Ingredients

Drugs in Phase 4 Trials (1)

Key: Kerry (0) Acquired (1)

ganedenbc30 (2 trials)

Drugs in Other Trials (3)

Key: Kerry (1) Acquired (2)

bacillus coagulans (1 trial)

beta-glucans (1 trial)

cellulase (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 4
  • # of Trial APIs: 4